Growth-inhibitory activity and downregulation of the class II tumor- suppressor gene H-rev107 in tumor cell lines and experimental tumors

Journal of Cell Biology

Volumn 136, Issue 4, 1997, Pages 935-944

  Sers, Christine ^a,b,d   Emmenegger, Urban ^a   Husmann, Knut ^a   Bucher, Katharina ^a   Andres, Ann Catherine ^c   Schäfer, Reinhold ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; DOWN REGULATION; GROWTH INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSGENE; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA; CARCINOMA, HEPATOCELLULAR; CELL LINE, TRANSFORMED; COLONIC NEOPLASMS; DOWN-REGULATION; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GROWTH INHIBITORS; INTRACELLULAR FLUID; LIVER NEOPLASMS; ORGAN SPECIFICITY; PANCREATIC NEOPLASMS; PROTEINS; RATS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; MUS MUSCULUS;

EID: 0031033127     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.136.4.935     Document Type: Article

References (53)

1. Andres, A.-C., C.-A Schönenberger, B. Groner, L. Henninghausen, M. LeMeurs, and P. Gerlinger. 1987. Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice. Proc. Natl. Acad. Sci. USA. 84:1299-1303.
2. Aoyama, A., and R. Klemenz. 1993. Oncogene-mediated effects on cellular gene expression. Crit. Rev. Oncog. 4:53-94.
3. Blobel, G. and V.R. Potter. 1966. Nuclei from rat liver: isolation method that combines purity with high yield. Science (Wash. DC). 154:1662-1665.
4. Bos, J.L. 1989. Ras oncogenes in human cancer: a review. Cancer Res. 49:4682-4689.
5. Cawthon, R.M., R. Weiss, G. Xu, D. Viskochil, M. Culver, J. Stevens, M. Robertson, D. Dunn. R. Gesteland, P. O'Connell, et al. 1990. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 62:193-201.
6. Chauhan, S.S., L.J. Goldstein, and M.M. Gottesman. 1991. Expression of cathepsin L in human tumors. Cancer Res. 51:1478-1481.
7. Chomzcynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium-thiocyonate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
8. Coghlan, V.M. B.A. Perrino, M. Howard, L.K. Langeberg, J.B. Hicks, W.M. Gallatin, and J.D. Scott. 1995. Association of protein kinase A and a protein phosphatase 2B with a common anchoring protein. Science (Wash. DC). 267:108-111.
9. Contente, S., K. Kenyon, D. Rimoldi, and R.M. Friedman. 1990. Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-Ha-ras. Science (Wash. DC). 249:796-798.
10. Culine, S., B. Olofsson, S. Gosselin, N. Honore and A. Tavitian 1989. Expression of the ras-related rap genes in human tumors. fnt. J. Cancer. 44:990-994.
11. Feinberg, A.P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
12. Femandez, J.L.R., B. Geiger, D. Salomon, I. Sabanay, M. Zoller, and A. Ben Ze-ev. 1992. Suppression of tumorigenicity in transformed cells after transfection with vinculinc DNA. J. Cell. Biol. 119:427-438.
13. Franza, B.R., Jr., K. Maruyama, J.I. Garrels, and H.E, Ruley. 1986. In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes. Cell. 44:409-418.
14. Frech, M., J. John, V. Pizon, P. Chardin, F. McCormick, A. Tavitian, A. Wittinghofer, and R. Clark. 1990. Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product. Science (Wash. DC). 249:169-171.
15. Geiges, D., F. Marks, and M. Gschwendt. 1995. Loss of protein kinase Cδ from human HaCaT keratinocytes upon Ras transfection is mediated by TGFα. Exp. Cell Res. 219:299-303.
16. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline responsive promoters. Proc. Natl. Acad. Sci. USA. 89:5547-5551.
17. Gossen, M., S. Freundlieb, G. Bender, G. Müller, W. Hillen, and H. Bujard. 1995. Transcriptional activation by tetracycline in mammalian cells. Science (Wash. DC). 268:1766-1769.
18. Griegel, S., O. Traub, K. Willecke, and R. Schäfer. 1986. Suppression and reexpression of transformed phenotype in hybrids of Ha-ras1 transformed Rat-1 cells and early passage rat embryo fibroblasts. Int. J. Cancer. 38:697-705.
19. Hajnal, A., R. Klemenz, and R. Schäfer. 1993. Upregulation of lysyl oxidase in spontaneous revenants of H-ras transformed rat fibroblasts. Canc. Res. 53:4670-4675.
20. Hajnal, A., R. Klemenz, and R. Schäfer. 1994. Subtraction cloning of H-rev 107. a gene specifically expressed in H-ras resistant fibroblasts. Oncogene. 9:479-490.
21. Hirakawa, T., and H.E. Ruley. 1988. Rescue of cells from oncogene-induced apoptosis by a second, complementing oncogene. Proc. Natl. Acad. Sci. USA. 85:1519-1523.
22. Kiess, M., B. Scharm, A. Aguzzi, A. Hajnal, R. Klemenz, I. Schwarte-Waldhoff, and R. Schäfer. 1995. Expression of ril, a novel LIM domain gene, is downregulated in HRAS-transformed cells and restored in phenotypic revenants. Oncogene. 10:61-68.
23. Kitayama, H., Y. Sugimoto.T. Matsuzaki, Y. Ikawa, and M. Noda. 1989. A rasrelated gene with transformation suppressor activity. Cell. 56:77-84.
24. Krzyzosiak, W.J., N. Shindookada, H. Teshima, K. Nakajima, and S. Nishimura. 1992. Isolation of genes specifically expressed in flat revenant cells derived from activated ras-transformed NIH-3T3 cells by treatment with azatyrosine. Proc. Natl. Acad. Sci. USA. 89:4879-4883.
25. Kumar, C.C., C. Prorock-Rogers, J. Kelly, Z. Dong, J.-J. Lin, L. Armstrong. H.-F. Kung, M.J. Weber, and A. Afonso. 1995. SCH 51344 inhibits ras transformation by a novel mechanism. Canc. Res. 55:5106-5117.
26. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of a head of bacteriophage T4. Nature (Lond.). 227:680-685.
27. Lee, S.W., C. Tomasetto, and R. Sager. 1991. Positive selection of candidate to mor-suppressor genes by subtractive hybridization. Proc. Natl. Acad. Sci. USA. 88:2825-2829.
28. Lee, S.W., C. Tomasetto, D. Paul, K. Keyomarsi, and R. Sager. 1992. Transcriptional downregulation of gap-junctional proteins blocks junctional communication in human mammary tumor cell lines. J. Cell Biol. 118:1213-1221.
29. Leevers, S.J.. H.F. Paterson, and C.J. Marshall. 1994. Requirement for Ras is Raf activation is overcome by targeting Raf to the plasma membrane. Nature (Lond.). 369:411-414.
30. Lin, X.Y., P.J. Nelson, B. Frankfort, E. Tombler, R. Johnson, and I.H. Gelman 1995. Isolation and characterization of a novel mitogenic regulatory gene 322, which is transcriptionally suppressed in cells transformed by src and ras Mol. Cell Biol. 15:2754-2762.
31. Marshall, M.S. 1995. Ras target proteins in eukaryotic cells. FASEB (Fed Am Soc. Exp. Biol.) J. 9:1311-1318.
32. McMaster, G.K., and G.G. Carmichael. 1977. Analysis of single- and double stranded nucleic acids on polacrylamide and agarose gels using glyoxal and acridine orange. Proc. Natl. Acad. Sci. USA. 74:4835-4838.
33. Mochly-Rosen, D., H. Khaner, and J. Lopez. 1991. Identification of intracellu- lar receptor proteins for activated protein kinase C. Proc. Natl. Acad Sci. USA. 88:3997-3400.
34. Muller, D., B. Quantin, M.-C. Gesnel, L.M. Matrisian, and R. Breathnl 1988. The collagenase gene family in humans consists of at least four mam- bers. Biochem. J. 253:187-192.
35. Müllauer, L., H. Fujita, A. Ishizaki, and N. Kuzumaki. 1993. Tumor-suppressive function of mutated gelsolin in ras-transformed cells. Oncogene. 8:2531-2536.
36. O'Brien, W., G. Stenman, and R. Sager. 1986. Suppression of tumor growth by senescence in virally transformed human fibroblasts. Proc. Natl. Acad. Sci. USA. 83:8659-8663.
37. Oberhuber, H., B. Seliger, and R. Schäfer. 1995. Partial restoration of pre- transformation levels of lysyl oxidase and transin mRNAs in phenotypic ras revertants. Mol. Carcinog. 12:198-204.
38. Prasad, G.L., R.A. Fuldner, and H.L. Cooper. 1993. Expression of transduced tropomyosin-1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc. Natl. Acad. Sci. USA. 90:7039-7043.
39. Quade, K. 1979. Transformation of mammalian cells by avian myelocytomato- sis virus and avian erythroblastosis virus. Virology. 98:461-465.
40. Riley, D.J., E.Y.-H.P. Lee, and W.H. Lee. 1994. The retinoblastoma protein: more than a tumor suppressor. Annu. Rev. Cell Biol. 10:1-29.
41. Schaffner, W., and C. Weissmann. 1973. A rapid and sensitive method for the determination of protein in dilute solution. Anal. Biochem. 56:502-514.
42. Schäfer, R.. J. Iyer, E. Iten, and A.C. Nirkko. 1988. Partial reversion of the transformed phenotype in HRAS-transfected tumorigenic cells by transfer of a human gene. Proc. Natl. Acad. Sci. USA. 85:1590-1594.
43. Schäfer, R. 1994. Suppression of ras oncogene-mediated transformation. Rev. Physiol. Biochem. Pharmacol. 124:29-9.
44. Scher, C.D., R.L. Dick, A.P. Whipple, and K.L. Locatell. 1983. Identification of a BALB/c-3T3 cell protein modulated by platelet-derived growth facu Mol. Cell. Biol. 3:70-81.
45. Shay, J.W., and W.E. Wright. 1991. Both Rb and P53 are potential regulator of human cellular senescence. Hereditary Tumors. 83:173-182.
46. Stanbridge, E.J. 1991. Human tumor suppressor genes. Annu. Rev. Genet. 24: 615-657.
47. Stokoe, D., S.D. Macdonald, K. Cadwallader, M. Symons, and J.F. Hancock. 1994. Activation of Raf as a result of recruitment to the plasma membrane. Science (Wash. DC). 264:1463-1467.
48. Viskochil, D., A.M. Buchberg, G. Xu, R.M. Cawthon, J. Stevens, R.K. Wolff. M. Culver J.C Carey, N.G. Copeland, N.A. Jenkins, et al. 1990. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 62:187-192.
49. Vogelstein, B., E.R. Fearon, S.R. Hamilton, S.E Kern, A.C. Presinger., M. Lep- pert, Y. Nakmura, R. White, A.M.M. Smits, and J.L. Bos. 1988. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319:526-532.
50. Vogelstein, B., and K.W. Kinzler. 1992. p53 function and dysfunction. Cell. 70: 523-526.
51. Wessel, D., and U.I. Függe. 1984. A method for quantitative recovery of pro- tein in dilute solution in the presence of detergents and lipids. Anal. Bio- chem. 138:141-143.
52. Wigler, M., A. Pellicer, S. Silverstein, and R. Axel. 1978. Biochemical transfer of single-copy eukaryotic genes using total cellular DNA as donor. Cell. 14:725-731.
53. Zou, Z., A. Anisowicz, M.J.C. Hendrix, A. Thor, M. Neveu, S. Sheng, K. Rafidi. E. Seftor, and R. Sager. 1994. Maspin, a serpin with tumor-suppressing activ- ity in human mammary epithelial cells. Science (Wash. DC). 263:526-529.